New Hampshire clarifies that the state appropriately covers and pays for routine patient costs of items and services for beneficiaries enrolled in qualifying clinical trials, as newly required under amendments made by Section 210 of the CAA. NH provides coverage for these costs already—no new items or services are being covered, and no payment methodologies are being changed.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media